CSTL Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Castle Biosciences Inc

Watchlist Manager

Watchlist

Price: 35.255 USD -0.77% Market Closed

Market Cap: $1.1B

	Castle Biosciences Inc NASDAQ:CSTL	US
W	Wynn Resorts Ltd XHAM:WYR	US
	Guangxi Wuzhou Zhongheng Group Co Ltd SSE:600252	CN
	Springfield Properties PLC F:9MZ	UK
	Theralase Technologies Inc XTSX:TLT	CA

Profitability Summary

Castle Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

77%

Strong 3Y Average Gross Margin

80%

Declining Gross Margin

78% > 77%

Negative Operating Margin

-9%

Negative 3Y Average Operating Margin

-12%

Operating Margin is Increasing

-45% > -9%

Negative Net Margin

-5%

Negative 3Y Average Net Margin

-8%

Net Margin is Increasing

-39% > -5%

Negative Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-22% > 0%

Negative ROE

-4%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-14%

ROIC is Increasing

-44% > -12%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

77%

Strong 3Y Average Gross Margin

80%

Declining Gross Margin

78% > 77%

Negative Operating Margin

-9%

Negative 3Y Average Operating Margin

-12%

Operating Margin is Increasing

-45% > -9%